management of patients with pv who are intolerant to interferon and who develop post-polycythemic mf
Published 1 year ago • 227 plays • Length 6:19Download video MP4
Download video MP3
Similar videos
-
2:14
risk-adapted treatment of et & pv
-
6:49
the role of interferon in polycythemia vera & perspectives on the management of low-risk patients
-
1:39
upcoming agents in et and pv
-
1:51
results for trial of lcl161 for pmf, post-pv mf, and post-et mf patients
-
6:53
mpns: differentiating between et, pv, and mf
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
1:35
pv-pinpoint: a study investigating the diagnosis and management of polycythemia vera in the uk
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
5:21
challenges in the treatment and management of et and the need to improve therapeutic approaches
-
4:48
an insight into the management of cytopenias in mf
-
1:28
comorbidities and treatment decisions in myelofibrosis
-
2:38
integrating molecular variables into prognostic models for patients with mpns
-
5:26
nct03194542 trial: luspatercept for the treatment of patients with anemic myelofibrosis
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:52
cytoreductive therapy for patients with pv
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia